Poliovirus, the causative agent of poliomyelitis (17) , is a human enterovirus that belongs to the family Picornaviridae. The virus, a nonenveloped particle, consists of a singlestranded RNA of plus-strand polarity and 60 copies each of four capsid proteins, VP1, VP2, VP3, and VP4, and occurs in three serologically distinct types, type 1, type 2, and type 3. The severe paralytic disease caused by poliovirus has been effectively controlled in developed countries through the use of attenuated live (10, 17, 21) or killed (22) vaccines. Paralytic poliomyelitis, however, remains a serious threat in many countries of the world, especially in developing countries where effective vaccination against poliomyelitis is not sufficiently inclusive.
Although the virtue of the oral live poliovirus vaccines (Sabin vaccines; Sabin 1, Sabin 2, and Sabin 3 vaccine strains) has been widely recognized, the Sabin vaccine strains have the inherent problem of the risk, albeit low, of reversion from the attenuated to the neurovirulent phenotype upon repeated passages. Indeed, a very small number of cases of paralytic poliomyelitis continue to occur in countries with extensive oral poliovirus vaccine programs (10) . Experimental evidence strongly suggests that most of these cases are caused by the vaccines themselves, especially type 2 (Sabin 2) and type 3 (Sabin 3) vaccines (4, 11) .
To date, cDNA copies of the approximately 7,500-nucleotide 3' poly(A)+ RNA of both the virulent and attenuated strains of all three poliovirus serotypes have been sequenced and cloned in Escherichia coli (5, 9, 14, 18, 24, 25, 27 Racaniello and Baltimore (19) assembled a full-length clone of the genome of the virulent Mahoney strain of type 1 poliovirus from subgenomic clones and showed that transfection of plasmid DNA from this clone would produce infectious poliovirus in cultured primate cells. An infectious cDNA clone of the genome of the Sabin 1 vaccine strain of type 1 poliovirus, which is the safest of the Sabin vaccines, was isolated by Omata et al. (16) . Virus recovered from HeLa S3 cells or African green monkey kidney (AGMK) cells transfected with the infectious Sabin 1 clone was shown to be indistinguishable from the Sabin 1 reference virus in regard to biochemical and biological properties including monkey neurovirulence (6, 16) . Thus, the genetic information of the Sabin 1 vaccine strain appears to be stably stored in the infectious cDNA clone.
The attenuated Sabin 1 strain was derived from the virulent Mahoney strain of type 1 poliovirus by multiple passages through host cells of nonhuman origin (20, 21) . In addition to their different potentials for causing disease, these two strains of virus differ in a number of biological characteristics that include the temperature sensitivity of growth (rct marker), bicarbonate concentration dependency of growth (d marker), and size of plaques.
The availability of the total nucleotide sequences and infectious cDNA clones of the genomes of the Mahoney and Sabin 1 strains made it possible to identify genome loci influencing the different biological characteristics by constructing and performing biological tests on recombinant viruses of the two strains. We recently constructed infectious recombinant plasmid clones from cDNA segments of the Mahoney and Sabin 1 RNAs and used them to analyze the influence of the genome regions on the biological properties of type 1 poliovirus (7, 13, 15 study, it was suggested that the genome loci including mainly the 5' noncoding region harbor a relatively strong determinant(s) influencing the neurovirulence or attenuation phenotype, although the determinants influencing attenuation are spread over several areas of the entire viral genome, and that virion surface characteristics such as antigenicity and immunogenicity have little correlation with neurovirulence (7, 13, 15) . These results suggest that it is possible to construct more stable (and hence safer) vaccine strains of type 2 (15, 16, 23) . To enhance the specific infectivity of these infectious cDNA clones, the full-length cDNAs of the Mahoney and Sabin 1 genomes were recloned into plasmid pSVA13, which carried the replication and transcription signals of simian virus 40 as well as the sequences encoding large T antigen (6) , and were designated as pVM (1) (Fig. 1 ) produced in AGMK cells transfected with these two infectious cDNA clones showed the biological characteristics of their corresponding authentic parental virus strains (6, 7, 15, 16) .
Allele replacement (7, 15) experiments were carried out on these two cDNA clones by using restriction cleavage sites of AatII (nucleotide position 1122), KpnI (position 3664), and BgIII (position 5601). As a result, four different infectious cDNA clones from segments of the Mahoney and Sabin 1 genomes were constructed and designated pVSM(1)IC8a(T), pVSM(1)IC-8b(T), pVSM(1)IC-lla(T), and pVSM(1) IC-llb(T). AGMK cells were transfected with 10 ,ug of closed-circular forms of these recombinant cDNA clones per plastic dish (diameter, 6 cm), and the corresponding viruses, designated PV1(SM)IC-8a, PV1(SM)IC-8b, PV1(SM)IC-lla, and PV1(SM)IC-llb, respectively (Fig. 1) , were recovered from the cells by the procedure previously reported (6, 7, 15, 16) . All recombinant viruses were grown at 33.5°C.
To construct intertypic recombinants between the Sabin 1 and Sabin 3 strains, we used plasmids pVS(1)IC-O(T), pVS(1)BB2 (14) , and pVS(3)2603 (27) to assemble recombinant clones of the genomes of both the strains by the strategy shown in Fig. 2 Viruses obtained as described above were passaged in AGMK cells with Hanks balanced medium 199 containing 0.1% bovine serum albumin and 0.225% sodium bicarbonate up to 10 more times at 37.5C by using the procedure repeatedly used in the Japan Poliomyelitis Research Institute (6). Passaged virus was obtained by quick freeze-thawing twice followed by centrifugation to remove cell debris and was stored at -20°C. The passaged isolates were tested for their in vitro phenotypic markers (see below) at the passage number indicated in Fig. 5 .
The reference virus of the Sabin 3 strain used in this study was F-310. This virus had been obtained by two passages of Leon 12a1b(SO; Sabin original strain) in primary cell cultures prepared from African green monkey kidney and is now being used as a type 3 oral poliovirus vaccine in Japan. Similarly, Leon is the reference for the virulent Leon strain of type 3 poliovirus.
Monkey neurovirulence tests. The titers of the viruses were determined by using primary-cultured cynomolgus monkey kidney cells (6, 15) . For the test to estimate neurovirulence of recombinant viruses between the virulent Mahoney and attenuated Sabin 1 strains, 0.5 ml of the virus suspension (107 50% tissue culture infective doses/ml) was inoculated into both right and left thalamuses of each of the seronegative cynomolgus monkeys (15) . For the test of an intertypic recombinant virus, PV1/3(SS)BN (6) , 0.1 ml of the virus suspension (107 50% tissue culture infective doses/ml) was inoculated intraspinally into each of the seronegative cynomolgus monkeys. Monkeys were sacrificed 17 days after the inoculation. Monkeys showing severe clinical poliomyelitis were sacrificed at the peak of the disease. A total of 38 sections of the central nervous system were prepared to score the intensity of histological lesions as previously described (6, 15) . Lesion scores were estimated by established procedures (2) .
Antigenicity. Antigenicities of viruses were tested by a modified enzyme-linked immunosorbent assay with neutralizing monoclonal or polyclonal antibodies specific to the poliovirus serotype as described previously (7). Serological identification tests were performed as follows. A 0.7-ml portion of the virus solution (1 x 108 to 3 x 108 50% tissue culture infective doses/ml) was mixed with the same volume of hyperimmune serum specific to each poliovirus serotype. After incubation at 37°C for 2 h, 0.2 ml each of the virusantibody mixture was added to AGMK cell cultures growing at the bottom of glass tubes. After incubation, the cell cultures were covered with 1 ml of Hanks balanced medium 199 containing 0.1% bovine serum albumin and 0.225% sodium bicarbonate and kept at 36°C for 7 days. The cytopathic effect displayed on AGMK cells was then estimated to identify the serotype of the virus.
In vitro phenotype marker tests. All tests were performed with primary-cultured cynomolgus monkey kidney cells. The reproductive capacity of viruses at different temperatures (rct marker) was investigated by measuring the virus titer on the cells at 36, 39, 39.5, and 40°C and at a sodium bicarbonate concentration of 0.225% after an incubation of 7 days as previously described (6, 7, 15, 16) .
Delayed growth (d marker) of viruses in media containing a low concentration of bicarbonate was investigated by measuring virus titers on the cells at 36°C and at sodium bicarbonate concentrations of 0.225, 0.08, and 0.03% after an incubation of 4 days as previously described (6, 7, 15, 16) .
For determination of plaque size produced by the different viruses, cells were infected and cultured under agar overlays at sodium bicarbonate concentrations of 0.225, 0.08, and 0.03% at 36°C. The diameters of approximately 100 plaques, observed on the days 3, 4, and 7 after infection, were measured as previously described (6, 7, 15 phenotype is not clear. This region of the genome includes sequences encoding most viral capsid proteins and whole P2 polyproteins.
To find the effect of the genome region on the attenuation phenotype, we constructed four recombinant viruses by using infectious cDNA clones as described previously (15) . The genome structures of these recombinant viruses are shown in Fig. 1 . These viruses were tested for their biological properties including monkey neurovirulence (Table 1) . In vitro phenotypic marker tests were also carried out on these viruses to confirm our previous assumption about the relationship between the monkey neurovirulence and in vitro markers (15) .
Viruses PV1(SM)IC-8b and PV1(SM)IC-llb showed fairly high lesion scores among the recombinants, although the lesion scores were clearly lower than that of the parental neurovirulent strain PV1(M)pDS306 (Table 1 (Table 1) . In contrast, viruses PV1(SM)IC-8b and PV1(SM)IC-lla showed similar biological properties to that of the virulent virus PV1(M)pDS306 in regard to these phenotypes (Table 1) . Since the first two and the last two viruses have Sabin-and Mahoney-derived capsid proteins, respectively (Fig. 1) , the results presented here confirm our previous assumption described above.
Construction Antigenicity of PV1/3(SS)BN. Virus PV1/3(SS)BN should have antigenicities specific to the Sabin 3 strain, since the genome of this virus codes for P1 polyprotein identical to that of the Sabin 3. Accordingly, we investigated the antigenicity of the recombinant virus by enzyme-linked immunosorbent assay (7) with strain-specific neutralizing monoclonal and polyclonal antibodies (Fig. 4) . PV1/3(SS)BN was recognized only by neutralizing monoclonal and polyclonal antibodies specific to type 3 poliovirus (Fig. 4) . The Table 3 . Eleven monkeys were used for the test of the reference virus, F-310, and seven monkeys were used for the recombinant virus, PV1/3(SS)BN.
The average lesion scores of PV1/3(SS)BN were lower than those of the reference virus. Furthermore, no paralytic syndrome was observed in the test animals injected with the recombinant virus or the reference virus (Table 3) . These results suggest that the recombinant virus is attenuated enough to be considered a candidate virus for the oral live poliovirus vaccine.
In vitro phenotypic markers of PV1/3(SS)BN. Many differences in biological characteristics between the virulent and attenuated poliovirus strains have been recognized in addition to their different potentials for causing disease. Of these, rct, d, and plaque size markers are frequently used as in vitro phenotypic markers to analyze properties of poliovirus strains. Indeed, all three Sabin vaccine strains share these in vitro characteristics. It is therefore possible that these in vitro phenotypes of the attenuated Sabin vaccine strains have some correlation with the viral pathogenesis, which includes numerous biological processes. Thus, it may be important to know the in vitro properties of the recombinant virus PV1/3(SS)BN if the virus is considered to be a possible candidate vaccine for type 3 poliovirus.
The results of rct marker, d marker, and plaque size marker tests on PV1/3(SS)BN and reference viruses are shown in Tables 4, 5 , and 6, respectively. The virus PV1/3(SS)BN showed temperature sensitivity similar to that of PV1(Sab)IC-0 and even greater than that of F-310 (Table  4 ). This result suggests that the segment exchanged in the recombinant virus genome (nucleotides 637 to 3405) of both the Sabin 1 and Sabin 3 strains harbors a determinant(s) influencing the temperature-sensitive growth of the virus.
The recombinant virus PV1/3(SS)BN showed a strong d phenotype ( Table 5 ). The degrees of d phenotype among PV1(Sab)IC-0, PV1/3(SS)BN, and F-310 were indistinguishable from one another when compared with the logarithmic differences of virus titers obtained at two different sodium bicarbonate concentrations, 0.225% and 0.03%. However, the logarithmic difference of PV1/3(SS)BN virus titers at 0.225% and 0.08% sodium bicarbonate was the greatest among these three virus strains (Table 5) . Thus, PV1/ 3(SS)BN appeared to have the strongest d phenotype of the Fig. 1 ; Table 1 ). Plaque sizes of the virus PV1/3(SS)BN and reference viruses measured on days 3, 4, and 7 after inoculation are shown in Table 6 . PV1/3(SS)BN showed a small-plaque phenotype. The plaque size of this recombinant virus was smaller than those of both parent viruses, PV1(Sab)IC-0 and F-310. This observation is very similar to the results of d marker tests. The determinant(s) influencing plaque size, therefore, may reside in the same areas as those influencing d phenotype.
Stability in rct phenotype of PV1/3(SS)BN. It has been established that high-quality poliovirus vaccines have more stable biological characteristics of the rct marker upon serial passage at elevated temperature in tissue culture cells (1, 6) . Accordingly, the recombinant virus PV1/3(SS)BN was passaged in AGMK cells up to 10 times at a temperature of 37.5°C, and the passaged isolates were then tested for their rct phenotype (Fig. 5) .
Logarithmic differences of virus titers obtained at two different temperatures (36 and 39°C) at the indicated passage number are shown in Fig. SA . The results show that PV1/ 3(SS)BN appears to be more stable than F-310 with respect to the rct marker during passaging. Similar results were obtained from the experiments done at 36 and 39.5°C (Fig.  SB) . These data suggest that PV1/3(SS)BN might be a higher-quality poliovirus vaccine than F-310.
DISCUSSION
Allele replacement experiments were performed with the virulent Mahoney and attenuated Sabin 1 strains. The results confirmed our previous observation (15) that surface parameters such as antigenicity and immunogenicity were not the In contrast, the recombinant virus PV1/3(SS)BN had a viability indistinguishable from those of the parent viruses in vitro, although the genomes of the Sabin 1 and Sabin 3 strains differ in 51 nucleotides in the 5' noncoding region downstream of the BalI cleavage site. These nucleotide differences, therefore, may not affect the functional structures probably formed in the 5' noncoding sequence (8) . This result is compatible with our previous observations that mutants lacking this genome region of highly variable sequence (27) were fully viable (8) . It is also suggested that the capsid precursor protein P1 of the Sabin 3 virus is correctly processed by the virus-specific proteinases of the Sabin 1 virus, although a number of amino acid differences are observed around the cleavage sites of polyprotein P1 between both the strains.
The recombinant virus PV1/3(SS)BN carries capsid proteins identical to those of the Sabin 3 
